New antibody GEN3018 tested in first human trial for relapsed blood cancers

NCT ID NCT07384715

First seen Feb 03, 2026 · Last updated Jun 15, 2026 · Updated 25 times

Summary

This study tests a new drug called GEN3018 in people whose acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (MDS) has returned or not responded to treatment. The main goal is to check safety and find the best dose. Up to 78 adults will receive the drug, and the study lasts about one year with regular check-ups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aarhus Universitetshospital - Skejby

    RECRUITING

    Aarhus, 8200, Denmark

  • Charite Campus Virchow-Klinikum

    NOT_YET_RECRUITING

    Berlin, Germany

  • Copenhagen Rigshospitalet

    RECRUITING

    Copenhagen, 2100, Denmark

  • Hospital Clínic de Barcelona

    NOT_YET_RECRUITING

    Barcelona, 08036, Spain

  • Hospital Universitari Vall d'Hebron

    NOT_YET_RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitari i Politècnic La Fe

    RECRUITING

    Valencia, 46026, Spain

  • Hospital Universitario 12 de Octubre

    NOT_YET_RECRUITING

    Madrid, 28041, Spain

  • Klinikum der Universität München Großhadern

    NOT_YET_RECRUITING

    Munich, Germany

  • Universitätsklinikum Carl Gustav Carus Dresden

    NOT_YET_RECRUITING

    Dresden, Germany

Conditions

Explore the condition pages connected to this study.